Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I look forward to your comments and questions... reprise

 

I find this answer interesting..note the use of the past tense "shared".."not continue to share" or "share"..imo this would negate the whole royality / contingency theory..however, the whole business resolution thing would still be open ended..and would not negate a future interest not yet determinable..partnership / joint venture..what about a future offering of stock that can't yet be priced??

4. Can you please reassure PTSC investors that the "business resolution" does not favour TPL at the expense of Patriot Scientific such as happened with the Sony signing?

A. PTSC and TPL through PDS shared in the expenses and the settlement proceeds.

Share
New Message
Please login to post a reply